Membership Directory
ImmusanT, Inc.
Category: Drug Development
Phone: + (617) 299-8399
Fax: + (508) 754-6916
Website: http://www.immusant.com
Location: Cambridge, MA
Therapeutic Areas: Autoimmune/Inflammatory, Gastrointestinal
ImmusanT is a privately-held biotechnology company focused on restoring tolerance to gluten in celiac disease by harnessing new discoveries in immunology that aim to improve diagnosis and treatment and return patients to a normal diet, good health and improved quality of life. The company is developing Nexvax2®, a therapeutic vaccine for celiac disease, and a companion diagnostic and monitoring tool to improve celiac disease management. ImmusanT's targeted immunotherapy discovery platform can be applied to a variety of epitope-specific autoimmune diseases. Founded in 2010, ImmusanT is backed by Vatera Healthcare Partners. More information can be found at www.ImmusanT.com.
